Trevi Therapeutics, Inc. TRVI Share-based compensation expense related to employee stock plans
Share-based compensation expense related to employee stock plans at other companies
Other financials
Where this comes from
Reported directly by Trevi Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue.
The official record: Trevi Therapeutics, Inc.’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Trevi Therapeutics, Inc.'s share-based compensation expense related to employee stock plans.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Trevi Therapeutics, Inc.'s share-based compensation expense related to employee stock plans?
- Trevi Therapeutics, Inc. (TRVI) reported share-based compensation expense related to employee stock plans of $2.19M in Q1 2026.
- How has Trevi Therapeutics, Inc.'s share-based compensation expense related to employee stock plans changed year-over-year?
- Trevi Therapeutics, Inc.'s share-based compensation expense related to employee stock plans increased by 81.4% year-over-year, from $1.21M to $2.19M.
- What is the long-term trend for Trevi Therapeutics, Inc.'s share-based compensation expense related to employee stock plans?
- Over 4 years (2021 to 2025), Trevi Therapeutics, Inc.'s share-based compensation expense related to employee stock plans has grown at a 19.5% compound annual growth rate (CAGR), from $2.54M to $5.19M.